Andrew Layton, BA

home / authors / andrew-layton-ba

Articles

Cost-Effectiveness of Extended-Release Carbidopa-Levodopa for Advanced Parkinson's Disease

Renée J.G. Arnold, PharmD, RPh;Andrew Layton, BA;Nathan R. Rustay, PhD;Susy Chen, MD

February 21st 2017

Existing levodopa therapies for Parkinson’s disease often provide inadequate symptom control after prolonged treatment. This study assessed the cost-effectiveness of an extended-release carbidopa-levodopa formulation (IPX066).

Mother holding baby's foot with measles spots | Image Credit: © rostock-studio - stock.adobe.com

Published: April 18th 2025 | Updated: April 21st 2025

Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders

Anatomy of Human Heart on medical background. 3d render - Image credit: ckybe | stock.adobe.com

Published: March 10th 2025 | Updated: March 21st 2025

Pharmacists Will Play an Essential Role in Optimizing Vutrisiran Therapy for ATTR-CM

Image credit: toeytoey | stock.adobe.com

Published: March 12th 2025 | Updated: March 18th 2025

MDMA Rejected: The Story of a Study Participant Entrenched in Ethical Violations

Blood test for graft-vs-host-disease (GVHD) -- Image credit: MdBabul | stock.adobe.com

Published: February 26th 2025 | Updated: March 14th 2025

Navigating Steroid-Refractory GVHD Treatment: A Pharmacist’s Guide to Medication Management

fda on paper texture - Image credit: Araki Illustrations | stock.adobe.com

Published: March 7th 2025 | Updated: March 10th 2025

FDA Approves Interchangeable Biosimilar to Xolair

Benjamin Franklin on US dollar surrounded by pills | Image Credit: © Cagkan - stock.adobe.com

Published: January 22nd 2025 | Updated: January 28th 2025

Reversal of Executive Order 14087 Raises Questions About Future Drug Pricing Reforms

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Andrew Layton, BA

Articles

Latest Updated Articles